Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Synthesis-of-soluble-beta-sheet-forming-peptides

 Monoclonal antibodies that block ligand binding to the CD22 receptor in mature B cells
The present invention provides such monoclonal antibodies, HB22, which identify a region of the CD22...


 PRO1312 polypeptides
1. PR0281 A cDNA clone (DNA16422-1209) has been identified, having homology to nucleic acid ...


 Purified p75 (type II) tumor necrosis factor receptor polypeptides
The present invention provides isolated TNF receptors and DNA sequences encoding mammalian tumor ...


 Derivatives of choline binding proteins for vaccines
OF THE INVENTION In accordance with an aspect of the present invention there is provided a vaccine ...


 Pneumococcal protein homologs and fragments for vaccines
OF THE INVENTION The present invention is directed to novel polynucleotides and polypeptides ...


 Bv8 nucleic acids and polypeptides with mitogenic activity
The present invention is based on the identification of novel activities of Bv8. In particular, Bv8 ...


 Four genetic tumor markers specific for human glioblastoma
We claim: 1. A method of specifically delivering a reagent to a glioblastoma, comprising the step ...


 Streptococcus pneumoniae 37-kDa surface adhesin a protein
OF THE INVENTION The present invention may be understood more readily by reference to the ...


 Peptides stimulating cytotoxic T cells immune to HIV RT
We claim: 1. A peptide consisting essentially of the following amino acid sequence: Cys-Thr-Glu-Met-...


 Molecularly cloned acquired immunodeficiency syndrome polypeptides and methods of use
In accordance with this invention, DNA encoding AIDS-associated polypeptides is identified and ...


 Synthesis of soluble .beta.-sheet forming peptides

Details
Inventors: Mayo, Kevin; Griffioen, Arjan W.;
Assignee: Regents of the University of Minnesota (Minneapolis, MN)
Primary Examiner: Patterson, Jr.; Charles L.
Assistant Examiner:
Attorney, Agent or Firm: Mueting, Raasch & Gebhardt, P.A.

This invention relates to the chemical design and production of peptides, peptide structure and three dimensional conformation was assessed using NMR, circular dichroisin and pulsed field gradient NMR. In addition, this invention relates to peptides produced by these methods and to methods for using the peptides.

DETAILED DESCRIPTION OF THE INVENTION An intricate interplay exists between peptide .
beta.
-sheet formation, self-association, and water solubility.
A challenge in making a soluble folded peptide is that solubility has a double-edged effect: precipitation versus over-solvation.
Precipitation is the falling out of solution of a peptide, while over-solvation is the tendency of a soluble peptide to prefer intermolecular water-peptide interactions over intramolecular folding interactions.
Going too far in either direction (precipitation or over-solvation) destabilizes the folded state.
Reduced solubility generally occurs due to intermolecular peptide-to-peptide interactions (hydrophobic and electrostatic) which results in precipitation or gelation.
Although the precipitate, for example, is in equilibrium with soluble peptide, the equilibrium is shifted away from solution.
If a designed .
beta.
-sheet-forming peptide contains a relatively large number of amino acids with hydrophobic side chains which are not screened to some extent by the folding process, precipitation or gelation may result.
Inherent in the design of .
beta.
-sheet forming peptides, therefore, is the capacity to self-associate, thereby screening hydrophobic surface from solvent water.
The present invention provides a method for the de novo design of peptides that are water soluble at or near physiological conditions and preferably form .
beta.
-sheet structures.
Preferably and advantageously, the water-soluble peptide forms, through self-association, a .
beta.
-sheet in the absence of any intermolecular covalent interactions (although this is not necessarily a requirement).
The method takes into account the following parameters: the number or percentage composition of amino acids with positively and negatively charged side chains, the number or percentage composition of amino acids with noncharged polar side chains, the number or percentage composition of amino acids with hydrophobic side chains, proper placement and pairing of amino acids in the sequence and in space, and specific turn character



Related patents
  Flavivirus antigen
What is claimed is: 1. An antigen consisting essentially of an amino acid sequence represented by the following formula (I): Phe Asn Cys Leu Gly Met Gly Asn Arg Asp Phe I...
  Poxvirus containing formulations and process for preparing stable poxvirus containing compositions
OF THE INVENTION The present invention provides poxvirus containing formulation, in particular an aqueous poxvirus containing formulation. The formulation, in ...
  Screening method for orthopoxvirus antivirals
What is claimed is: 1. An assay comprising the steps of: infecting cultured cells with vaccinia virus; co-transfecting the cells with one or more plasmids comprising DNA ...
  Fibrinogen receptor antagonists
OF THE INVENTION Compounds of the invention are fibrinogen receptor antagonists which inhibit fibrinogen induced platelet aggregation. These compounds are prepared by ...
  Cyclic peptides containing Arg-Gly-Asp, and derivatives thereof, as adhesion inhibitors
We claim: 1. A cyclopeptide compound of formula I cyclo-(Arg-B-Asp-D-E) I, wherein: B is Gly, Ala, or--HN--Q--CO--; D is Phe, 4-Hal-Phe, Nal, or Phig; E is Gly, Ala, Lys,...
  Platelet aggregation inhibitors
We claim: 1. A method of treating or preventing a platelet associated ischemic disorder in a patient comprising administering to said patient an effective amount of a ...
  Adhesion receptor antagonists
What is claimed is: 1. An oxazolidinone compound of formula I ##STR10## wherein R.sup.1 is ##STR11## R.sup.2 is H, A, Ac, A--SO.sub.2 --, Ar--SO.sub.2 -- or the amino ...
  Activation of peptide prodrugs by hK2
What is claimed is: 1. A composition comprising a prodrug, the prodrug comprising a therapeutically active drug; and a peptide comprising an amino acid sequence having a ...
  Device having diarrhea diagnostic panel
The present invention is directed to a device that comprises a sensor adapted to detect one or more specific health and/or nutrition markers in feces. The device may ...
  Method for the treatment of chemonucleolysis
A method of this invention involves a treatment comprising administering to a mammal in need of chemonucleolysis an effective proteoglycan cleaving amount of a ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved